PSTV – Plus Therapeutics Inc
PSTV — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
18.03
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
EPS Last/This Y
2.47
EPS This/Next Y
2.43
Price
6.62
Target Price
38
Analyst Recom
1.4
Performance Q
-3.09
Upside
-1,836.7%
Beta
1.42
Ticker: PSTV
22 items
«
‹
of 1
›
»
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-04-23 | PSTV | 7.19 | N/A | N/A | 0 |
| 2026-04-24 | PSTV | 6.59 | N/A | N/A | 0 |
| 2026-04-27 | PSTV | 6 | N/A | N/A | 0 |
| 2026-04-28 | PSTV | 5.95 | N/A | N/A | 0 |
| 2026-04-29 | PSTV | 5.6 | N/A | N/A | 0 |
| 2026-04-30 | PSTV | 6.07 | N/A | N/A | 0 |
| 2026-05-01 | PSTV | 6 | N/A | N/A | 0 |
| 2026-05-04 | PSTV | 6.36 | N/A | N/A | 0 |
| 2026-05-05 | PSTV | 6.24 | N/A | N/A | 0 |
| 2026-05-06 | PSTV | 6.04 | N/A | N/A | 0 |
| 2026-05-07 | PSTV | 5.96 | N/A | N/A | 0 |
| 2026-05-08 | PSTV | 6.14 | N/A | N/A | 0 |
| 2026-05-11 | PSTV | 6.06 | N/A | N/A | 0 |
| 2026-05-12 | PSTV | 5.85 | N/A | N/A | 0 |
| 2026-05-13 | PSTV | 5.72 | N/A | N/A | 0 |
| 2026-05-14 | PSTV | 5.77 | N/A | N/A | 0 |
| 2026-05-15 | PSTV | 5.25 | N/A | N/A | 0 |
| 2026-05-18 | PSTV | 5.85 | N/A | N/A | 0 |
| 2026-05-19 | PSTV | 5.83 | N/A | N/A | 0 |
| 2026-05-20 | PSTV | 6.45 | N/A | N/A | 0 |
| 2026-05-21 | PSTV | 6.82 | N/A | N/A | 0 |
| 2026-05-22 | PSTV | 6.7 | N/A | N/A | 0 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
22 items
«
‹
Current Page1 of 1
›
»
21 items
«
‹
of 1
›
»
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-04-23 | PSTV | 7.22 | 93.9 | - | -3.82 |
| 2026-04-24 | PSTV | 6.55 | 93.9 | - | -3.82 |
| 2026-04-27 | PSTV | 5.99 | 93.9 | - | -3.82 |
| 2026-04-28 | PSTV | 5.92 | 93.9 | - | -3.82 |
| 2026-04-30 | PSTV | 6.12 | 93.9 | - | -3.82 |
| 2026-05-01 | PSTV | 6.06 | 93.9 | - | -3.82 |
| 2026-05-04 | PSTV | 6.36 | 93.9 | - | -3.82 |
| 2026-05-05 | PSTV | 6.23 | 93.9 | - | -3.82 |
| 2026-05-06 | PSTV | 6.01 | 93.9 | - | -3.82 |
| 2026-05-07 | PSTV | 5.97 | 93.9 | - | -3.82 |
| 2026-05-08 | PSTV | 6.14 | 93.9 | - | -3.82 |
| 2026-05-11 | PSTV | 6.03 | 93.9 | - | -3.82 |
| 2026-05-12 | PSTV | 5.84 | 93.9 | - | -3.82 |
| 2026-05-13 | PSTV | 5.72 | 93.9 | - | -3.82 |
| 2026-05-14 | PSTV | 5.76 | 93.9 | - | -3.82 |
| 2026-05-15 | PSTV | 5.25 | 93.9 | - | -3.82 |
| 2026-05-18 | PSTV | 5.86 | 93.9 | - | -3.82 |
| 2026-05-19 | PSTV | 5.77 | 93.9 | - | -3.82 |
| 2026-05-20 | PSTV | 6.40 | 93.9 | - | -3.82 |
| 2026-05-21 | PSTV | 6.79 | 93.9 | - | -3.82 |
| 2026-05-22 | PSTV | 6.62 | -464.6 | - | -4.78 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
21 items
«
‹
Current Page1 of 1
›
»
22 items
«
‹
of 1
›
»
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-04-23 | PSTV | 83.64 | 0 | 14.04 |
| 2026-04-24 | PSTV | 83.62 | 0 | 14.04 |
| 2026-04-27 | PSTV | 83.62 | 0 | 19.77 |
| 2026-04-28 | PSTV | 83.62 | 0 | 19.77 |
| 2026-04-29 | PSTV | 83.64 | 0 | 19.77 |
| 2026-04-30 | PSTV | 83.62 | 0 | 19.77 |
| 2026-05-01 | PSTV | 83.61 | 0 | 19.77 |
| 2026-05-04 | PSTV | 83.62 | 4.20 | 19.77 |
| 2026-05-05 | PSTV | 83.62 | 4.20 | 19.77 |
| 2026-05-06 | PSTV | 0.00 | 4.20 | 19.77 |
| 2026-05-07 | PSTV | 0.00 | 4.20 | 19.77 |
| 2026-05-08 | PSTV | 0.00 | 4.20 | 19.77 |
| 2026-05-11 | PSTV | 0.00 | 4.21 | 19.77 |
| 2026-05-12 | PSTV | 0.00 | 4.21 | 18.08 |
| 2026-05-13 | PSTV | 0.00 | 4.21 | 18.08 |
| 2026-05-14 | PSTV | 0.00 | 4.21 | 18.08 |
| 2026-05-15 | PSTV | 0.00 | 4.21 | 18.08 |
| 2026-05-18 | PSTV | 0.00 | 4.19 | 18.08 |
| 2026-05-19 | PSTV | 0.00 | 4.19 | 18.08 |
| 2026-05-20 | PSTV | 0.00 | 4.19 | 18.03 |
| 2026-05-21 | PSTV | 0.00 | 4.19 | 18.03 |
| 2026-05-22 | PSTV | 0.00 | 4.19 | 18.03 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
22 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
-0.92
Avg. EPS Est. Next Quarter
-0.91
Insider Transactions
Institutional Transactions
4.19
Beta
1.42
Average Sales Estimate Current Quarter
1
Average Sales Estimate Next Quarter
1
Fair Value
Quality Score
15
Growth Score
23
Sentiment Score
86
Actual DrawDown %
99.4
Max Drawdown 5-Year %
-99.7
Target Price
38
P/E
Forward P/E
PEG
P/S
8.76
P/B
3.06
P/Free Cash Flow
EPS
-3.27
Average EPS Est. Cur. Y
-4.78
EPS Next Y. (Est.)
-2.35
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-306.66
Relative Volume
0.4
Return on Equity vs Sector %
-126.8
Return on Equity vs Industry %
-111.2
EPS 1 7Days Diff
-0.9
EPS 1 30Days Diff
-4.78
EBIT Estimation
◆
PSTV
Healthcare
$6.59
📉
Swing / Pullback
Buy the dip on strong trends
WEAK
Trend
6/20
Pullback
10/25
Volume
11/15
Valuation
12/20
TP/AR
6/10
Options
0/10
RSI
56.6
Range 1M
62.7%
Sup Dist
1.5%
🚀
N/A
Momentum Growth
Ride accelerating trends
WEAK
Momentum
4/25
Growth
20/30
Estimates
6/20
Inst/Vol
4/15
Options
0/10
EPS Yr
46.6%
EPS NY
38.9%
52W%
18.3%
💎
N/A
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+476.6% upside
Quality
6/30
Valuation
16/30
Growth
17/25
Stability
7/10
LT Trend
2/5
Upside
+476.6%
Quality
15
Click a card to see score breakdown
Full Analysis →
Sector: Healthcare
Industry: Biotechnology
Employees: 28
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. The company's lead radiotherapeutic candidate is rhenium obisbemeda, a patented radiotherapy for patients with central nervous system and other cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. It also develops Rhenium-188 NanoLiposome Biodegradable Alginate Microsphere to treat various solid organ cancers, such as primary and secondary liver cancers by intra-arterial injection. In addition, it develops and commercializes laboratory-developed tests comprising the CNSide Test to identify tumor cells that have metastasized to the central nervous system in patients with carcinomas and melanomas. The company was formerly known as Cytori Therapeutics, Inc. and changed its name to Plus Therapeutics, Inc. in July 2019. Plus Therapeutics, Inc. was founded in 1996 and is headquartered in Houston, Texas.
PSTV
Latest News
—
Caricamento notizie per PSTV…
stock quote shares PSTV – Plus Therapeutics Inc Stock Price stock today
news today PSTV – Plus Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch PSTV – Plus Therapeutics Inc yahoo finance google finance
stock history PSTV – Plus Therapeutics Inc invest stock market
stock prices PSTV premarket after hours
ticker PSTV fair value insiders trading